Understanding mucosal responsiveness: Lessons from enteric bacterial pathogens

Seminars in Immunology

Volumn 13, Issue 3, 2001, Pages 201-209

  Simmons, Cameron P ^a   Clare, Simon ^a   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bacteria; Epithelia; Gastrointestinal; Pathogen

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ENTEROBACTERIACEAE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MUCOSA; NONHUMAN; REVIEW;

EID: 0034960050     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2001.0313     Document Type: Article

References (60)

1. Tolerance and immunity in the intestinal immune system
2. Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: Conversations between the microflora, epithelium, and diffuse GALT
3. Influences of microbiota on intestinal immune system development
4. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
5. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
6. Recent developments in the immunology of inflammatory bowel disease
7. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
8. Enterotoxigenic Escherichia coli (ETEC) in farm animals
9. Escherichia coli as a pathogen in dogs and cats
10. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine
11. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen
12. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
13. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
14. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
15. Helper T cell subsets for immunoglobulin a responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues
16. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
17. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
18. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
19. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
20. Bacterial toxins as mucosal adjuvants
21. Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses
22. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit
23. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity
24. Protection against Helicobacter pylori-infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
25. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
26. Inhibition of class II major histocompatibility complex antigen processing by Escherichia coil heat-labile enterotoxin requires an enzymatically active A subunit
27. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression
28. Cholera toxin increases intracellular pH in B lymphoma cells and decreases their antigen-presenting ability
29. Dendritic cells and the control of immunity
30. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin-10 and induce the differentiation of T helper type 2 cells
31. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch
32. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria
33. Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches
34. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
35. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
36. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
37. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes
38. Immunological memory after immunization with oral cholera B subunit - Whole-cell vaccine in Swedish volunteers
39. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene
40. Enteropathogenic Escherichia coli: A pathogen that inserts its own receptor into host cells
41. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12
42. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells
43. Type III secretion machines: Bacterial devices for protein delivery into host cells
44. Exploitation of host cells by enteropathogenic escherichiacoli
45. Lineage commitment and maturation of epithelial cells in the gut
46. Toll signaling pathways in the innate immune response
47. Antimicrobial peptides as mediators of epithelial host defense
48. Paneth cell defensins: Endogenous peptide components of intestinal host defense
49. Paneth cells and innate immunity in the crypt microenvironment
50. Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs
51. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
52. Role of the putative glycopeptide of intestinal mucin in binding of piliated Escherichia coli serotype O157:H7 strain CL-49
53. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells
54. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo
55. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability
56. Pathogenic Escherichia coli increase Cl-secretion from intestinal epithelia by upregulating galanin-1 receptor expression
57. Galanin causes Cl-secretion in the human colon. Potential significance of inflammation-associated NF-kappa B activation on galanin-1 receptor expression and function
58. Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens
59. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation
60. Enteropathogenic Escherichia coli inhibits phagocytosis